Rochester, NY 7/14/2009 11:35:21 PM
News / Finance

RPRX - Repros Therapeutics Announces Agreement with National Institutes of Health

Repros Therapeutics Inc., RPRX

WhisperFromWallStreet.com offers daily stock alerts to subscribers. 
Sign up for our free alerts newsletter.

Repros Therapeutics Inc. announced that it entered into the Sixth Amendment to its Agreement with the National Institutes of Health (NIH) relating to the Company`s product Proellex. The Amendment clarified that certain cancers related to the human reproductive system are within the scope of the licensed field, amended the development and commercialization benchmarks that the Company is required to meet under the Agreement and added or modified certain payments due to NIH on the achievement of certain benchmarks. Most significantly, the Amendment revised the dates by which certain development and commercialization benchmarks must be met.

About
WhisperFromWallStreet.com

WhisperfromWallStreet.com is a FREE award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, as well as teaching you how to become a better trader. We scan hundreds of stocks a day to find those that meet our criteria and when we find one, we send you an alert.

Sign up for our FREE alerts newsletter at WhisperfromWallStreet.com

Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php